全文获取类型
收费全文 | 1004篇 |
免费 | 84篇 |
国内免费 | 28篇 |
专业分类
儿科学 | 61篇 |
妇产科学 | 12篇 |
基础医学 | 84篇 |
口腔科学 | 48篇 |
临床医学 | 154篇 |
内科学 | 227篇 |
皮肤病学 | 13篇 |
神经病学 | 20篇 |
特种医学 | 253篇 |
外科学 | 62篇 |
综合类 | 20篇 |
预防医学 | 62篇 |
眼科学 | 4篇 |
药学 | 55篇 |
中国医学 | 4篇 |
肿瘤学 | 37篇 |
出版年
2021年 | 7篇 |
2020年 | 3篇 |
2019年 | 6篇 |
2018年 | 16篇 |
2017年 | 9篇 |
2016年 | 10篇 |
2015年 | 16篇 |
2014年 | 20篇 |
2013年 | 13篇 |
2012年 | 11篇 |
2011年 | 16篇 |
2010年 | 39篇 |
2009年 | 26篇 |
2008年 | 17篇 |
2007年 | 31篇 |
2006年 | 28篇 |
2005年 | 22篇 |
2004年 | 17篇 |
2003年 | 24篇 |
2002年 | 16篇 |
2001年 | 19篇 |
2000年 | 17篇 |
1999年 | 22篇 |
1998年 | 60篇 |
1997年 | 71篇 |
1996年 | 80篇 |
1995年 | 48篇 |
1994年 | 39篇 |
1993年 | 44篇 |
1992年 | 28篇 |
1991年 | 18篇 |
1990年 | 27篇 |
1989年 | 45篇 |
1988年 | 46篇 |
1987年 | 33篇 |
1986年 | 38篇 |
1985年 | 38篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 12篇 |
1981年 | 10篇 |
1980年 | 12篇 |
1979年 | 3篇 |
1978年 | 4篇 |
1977年 | 13篇 |
1976年 | 10篇 |
1975年 | 6篇 |
1969年 | 1篇 |
1966年 | 1篇 |
1950年 | 1篇 |
排序方式: 共有1116条查询结果,搜索用时 343 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
5.
Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. 总被引:4,自引:1,他引:3
下载免费PDF全文
![点击此处可从《Antimicrobial agents and chemotherapy》网站下载免费的PDF全文](/ch/ext_images/free.gif)
6.
7.
8.
S M Haffner K K Gruber P A Morales H P Hazuda R A Valdez B D Mitchell M P Stern 《American journal of epidemiology》1992,136(9):1060-1068
There is considerable evidence that lipoprotein(a) (Lp(a)) is a strong independent risk factor for coronary heart disease. Based on their risk factor profile, Mexican Americans have an increased risk of coronary heart disease, yet Mexican Americans have coronary heart disease mortality similar to or lower than that of non-Hispanic whites. The authors therefore attempted to determine whether Mexican Americans had decreased Lp(a) concentrations relative to non-Hispanic whites in the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. Lp(a) concentrations (mg/dl) were significantly lower in Mexican Americans (n = 316) than in non-Hispanic whites (n = 242) (men: 10.4 vs. 16.3; women: 11.5 vs. 16.4). In addition, the proportion of persons with Lp(a) concentrations of > or = 30 mg/dl (the threshold at which increased risk of coronary heart disease is believed to occur) was significantly higher in non-Hispanic whites than in Mexican Americans (18.6% vs. 7.6%; Mantel-Haenszel odds ratio (adjusted for sex) = 2.79). Age, obesity, body fat distribution, cigarette smoking, alcohol consumption, and glucose and insulin concentrations were not significantly related to Lp(a) levels. Decreased Lp(a) concentrations may account in part for Mexican Americans' relative protection from coronary heart disease mortality. 相似文献
9.
10.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献